Cryopyrin-Associated Periodic Syndromes

Search with Google Search with Bing
Information
Disease name
Cryopyrin-Associated Periodic Syndromes
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00685373 Completed Phase 3 Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease May 2008 April 2010
NCT00991146 Completed Phase 3 Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase October 2009 February 2012
NCT01302860 Completed Phase 3 Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease November 2010 November 2014
NCT01576367 Completed Phase 3 Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease January 16, 2012 October 13, 2015
NCT02326376 Completed Kineret CAPS Post Authorisation Study April 24, 2015 September 12, 2019
NCT03923140 Recruiting Phase 2 A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS) May 23, 2019 October 2024
MeSH unique ID (MeSH (Medical Subject Headings))
D056587